Preparations for AIDS vaccine trials. Intellectual property issues related to AIDS vaccine development from a federal laboratory perspective.
Mays
T D
TD
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-3100.
Maurey
K
K
D016915:AIDS Vaccines / Q000302:isolation & purification*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D009316:National Institutes of Health (U.S.); D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States
D016915:AIDS Vaccines